High androgen receptor levels are predictive of decreased survival in prostate cancer.
Lee
David
D
D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D016022:Case-Control Studies; D046508:Culture Techniques; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D011336:Probability; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D011944:Receptors, Androgen / Q000032:analysis*; D012016:Reference Values; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D014408:Biomarkers, Tumor; D011944:Receptors, Androgen